Hemp, Inc. (HEMP: OTC Pink Current) | Notification of Late
Top 10 Most Recent News Articles
Nuvo's INVU™ Trial Reveals Boost in Fetal Monitoring
Remote Fetal Monitoring: A Game Changer in Prenatal Care? In the world of high-risk pregnancies, routine checkups aren't just a suggestion—they're vital. But when the logistics of shuttling back and forth to clinics get tangled with everyday life, something's gotta give. Enter Nuvo's INVU™. The REACTIVE trial, a Penn Medicine-led event funded by the NIH, aimed to see...
Continue Reading
Freedom Bank Taps McIntyre as CRE Powerhouse Leader
Dan McIntyre's latest move to Freedom Bank of Virginia as Senior Vice President screams strategy. This isn’t just another shuffle of executive chairs—it’s a calculated play to deepen their roots in the fiercely competitive Washington D.C. real estate market. Now, why should investors like you sit up and take notice? Well, when a bank with hefty capital and a yawning...
Continue Reading
Personalized Brain Stimulation: Hope for Mental Health?
Brain Stimulation Tailored to the Individual Picture this—mental health treatments that don’t just throw a one-size-fits-all solution at you. That's what's cooking at NUH and NUS Medicine in Singapore, where innovative minds are diving deep into personalized brain stimulation. Regular transcranial magnetic stimulation (TMS) has been around, helping somewhat, but it...
Continue Reading
Flexcompute's Physics Twin Revolutionizes Space Docking
There's a new player shaking up the space game, and it's called the Physics Twin. Flexcompute, a trailblazer in AI-driven physics modeling, just rolled this out to help figure out how thruster plumes mess with nearby spacecraft. Trust me, this ain't your garden-variety simulation tool. Why Thruster Plumes Matter If you're in the business of dancing spacecraft around each...
Continue Reading
Pharmaceutical Navigator ASTHO's Podcast Earns Bronze Anthem Award
An Award to Nod At: ASTHO's Public Health Triumph The world of public health isn't generally where you'd find shiny accolades flying around, but when they do, it's worth taking notice. Recently, ASTHO’s podcast, the Public Health Review Morning Edition, snagged a Bronze Anthem Award. Sure, it isn't the gold trophy, but in this high-stakes arena, any medal's a feat! More...
Continue Reading
Ecobat Workers Secure Landmark Three-Year Contract
A Breakthrough for Ecobat Workers Man, when it comes to contracts, this recent deal at Ecobat is as game-changing as they get. A vote just ripped through like a hurricane, with 220 workers under Teamsters Local 986 eagerly ratifying a new three-year agreement that signals more than just a better payday. We're talking the largest wage boost these folks have clapped eyes on...
Continue Reading
AI Factory Revolution: PortCon 2026 Ignites Innovation
Shaking Up the Software Game November 2026 is set to be a standout period for tech aficionados, as Port, the AI Software Factory platform, rolls out the red carpet for PortCon, the inaugural AI Software Factory Summit, in San Francisco. This summit is no small fry in the industry kettle—it's going to be a rendezvous where tech heavyweights, including the likes of Uber,...
Continue Reading
Globee® AI Awards Calls For Global Innovation Entries
Rolling Out the Red Carpet for AI Innovators Worldwide Here's a call to all the boundary-pushing eggheads tinkering with artificial intelligence. The Globee® Awards is opening its doors again for the 3rd Annual AI showdown, inviting nominations from the creative minds conjuring up AI magic across the globe. This ain't your grandma's science fair; we're talking real-world...
Continue Reading
Vaudit Welcomes Industry Veteran David Coleman
David Coleman: Vaudit's New Ad Chief David Coleman stepping into Vaudit's spotlight as President of Advertising Industry is a twist worth watching. Vaudit, for those not up to speed, is an AI-driven powerhouse that keeps vendors in line with what they're charging. And let me tell you, Coleman's kind of heavy-hitter leadership doesn't come cheap, nor does it play nice with...
Continue Reading
Menarini & Ryvu's Phase II Results Offer Hope in B-NHL
New Glimmers of Hope in B-cell NHL Battle Battling aggressive B-cell non-Hodgkin lymphoma (B-NHL) isn't for the faint of heart, especially when standard treatments have been run through like an old pair of boots. Enter dapolsertib, the fresh-faced newcomer in Menarini Group and Ryvu Therapeutics' arsenal, showing encouraging signals in early Phase II results. These...
Continue Reading